- Home
- SLS vs MASS Comparison
SLS vs MASS Comparison
Compare SLS & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLS | MASS |
|---|---|---|
| Founded | 2012 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.0M | 224.4M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | SLS | MASS |
|---|---|---|
| Price | $3.61 | $6.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $7.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 5.6M | 389.8K |
| Earning Date | 03-19-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $65,045,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $19.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 36.21 |
| 52 Week Low | $0.95 | $1.92 |
| 52 Week High | $5.18 | $9.34 |
Technical Indicators
Market Signals| Indicator | SLS | MASS |
|---|---|---|
| Relative Strength Index (RSI) | 45.35 | 52.64 |
| Support Level | $3.46 | $6.23 |
| Resistance Level | $3.90 | $6.95 |
| Average True Range (ATR) | 0.33 | 0.35 |
| MACD | -0.11 | -0.01 |
| Stochastic Oscillator | 4.96 | 42.70 |
Price Performance
Historical ComparisonAbout SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.